C2825314||MicroRNA 101b
C0013081||Downregulated
C0162783||Prefrontal Cortex
C0026343||Genetic Model
C0011581||Depression
C0061467||Glutamate Transporter
C1529079||SLC1A1
C1529079||EAAT3
C1101610||MicroRNAs
C1101610||MicroRNAs
C1519619||translational repression
C2263416||base pairing with target mRNAs
C2825314||miRNA
C0017262||expression
C0087111||treatment
C1269683||major depressive disorder
C1269683||major depressive disorder
C2825314||miRNA
C0017262||expression
C0005507||assay
C2825314||MicroRNAs
C1979963||profile
C0162783||prefrontal cortex
C0162783||prefrontal cortex
C0026343||genetic rat model
C1269683||major depressive disorder
C0026343||Flinders Sensitive Line
C0026343||Flinders Sensitive Line
C0026343||Flinders Resistant Line
C0026343||Flinders Resistant Line
C0017262||Gene expression
C0162783||prefrontal cortex
C0026343||Flinders Sensitive Line
C0026343||Flinders Resistant Line
C0003062||animals
C0035696||mRNA
C0005507||Luciferase reporter assays
C2825314||miRNA
C2825314||MicroRNAs
C0013081||downregulated
C0162783||prefrontal cortex
C0026343||FSL model
C2825314||MicroRNAs
C2825314||miR-101b
C0086893||rat
C0086418||human
C0013081||downregulated
C0162783||prefrontal cortex
C1579931||depressed
C0038661||suicide
C0936012||analyses
C2825314||miR-101b
C0027882||neuronal
C0061467||glutamate transporter
C1529079||SLC1A1
C1529079||EAAC1
C1529079||EAAT3
C0035696||mRNA
C0428479||protein levels
C1529079||SLC1A1
C0041904||upregulated
C0162783||prefrontal cortex
C0026343||FSL model
C2825314||MicroRNAs
C0344315||depression-like states
C1709631||preclinical study
C0086418||human
C2825314||miR-101
C0011581||depression
C2825314||miR-101b
C0061467||glutamate transporter
C0242899||glutamatergic
C0243095||dysregulation
C0011581||depression